Oliver Von Bohlen Und Halbach.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Oliver Von Bohlen Und Halbach.Pdf Oliver von Bohlen und Halbach and Rolf Dermietzel Neurotransmitters and Neuromodulators Related Titles Thiel, G. (ed.) Transcription Factors in the Nervous System Development, Brain Function, and Diseases 2006 ISBN 3-527-31285-4 Becker, C.G., Becker, T. (eds.) Model Organisms in Spinal Cord Regeneration 2006 ISBN 3-527-31504-7 Bähr, M. (ed.) Neuroprotection Models, Mechanisms and Therapies 2004 ISBN 3-527-30816-4 Frings, S., Bradley, J. (eds.) Transduction Channels in Sensory Cells 2004 ISBN 3-527-30836-9 Smith, C.U.M. Elements of Molecular Neurobiology 2003 ISBN 0-471-56038-3 Oliver von Bohlen und Halbach and Rolf Dermietzel Neurotransmitters and Neuromodulators Handbook of Receptors and Biological Effects 2nd completely revised and enlarged edition The Authors n All books published by Wiley-VCH are carefully produced. Nevertheless, authors, Dr. Oliver von Bohlen und Halbach editors, and publisher do not warrant the Department of Anatomy and Cell Biology information contained in these books, University of Heidelberg including this book, to be free of errors. Im Neuenheimer Feld 307 Readers are advised to keep in mind that 69120 Heidelberg statements, data, illustrations, procedural Germany details or other items may inadvertently be inaccurate. Prof. Dr. med. Rolf Dermietzel Department of Neuroanatomy and Molecular Brain Research Library of Congress Card No.: applied for University of Bochum British Library Cataloguing-in-Publication Data Universitätsstr. 150 A catalogue record for this book is available 44780 Bochum from the British Library. Germany Bibliographic information published by the Deutsche Nationalbibliothek The Deutsche Nationalbibliothek lists this publica- tion in the Deutsche Nationalbibliografie; detailed bibliographic data are available in the Internet at http://dnb.d-nb.de. © 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany All rights reserved (including those of translation into other languages). No part of this book may be reproduced in any form – by photoprinting, microfilm, or any other means – nor transmitted or translated into a machine language without written permission from the publishers. Registered names, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered unprotected by law. Printed in the Federal Republic of Germany Printed on acid-free paper Composition K+V Fotosatz GmbH, Beerfelden Printing betz-druck GmbH, Darmstadt Bookbinding Litges & Dopf Buchbinderei GmbH, Heppenheim ISBN-13: 978-3-527-31307-5 ISBN-10: 3-527-31307-9 V Contents Preface for the Second Edition XIII Preface for the First Edition XV 1 Introduction 3 1.1 Neuroactive Substances 3 1.1.1 Neurotransmitters 4 1.1.2 Neuromodulators 5 1.2 Receptors and Transporters 8 1.2.1 Ionotropic Receptors 9 1.2.2 Metabotropic Receptors 10 1.2.3 Receptor Regulation 13 1.2.4 Transporters 14 1.3 Distribution and Localization of Neurotransmitters and Neuromodulators 15 1.4 The Blood–Brain Barrier 16 1.5 Volume Transmission and Wiring Transmission 18 2 Methods 21 2.1 Bio- and Radioisotope Assays 22 2.2 Microdialysis and Electrochemical Detection 24 2.2.1 Microdialysis 24 2.2.2 Electrochemical Detection 24 2.3 Chromatography 26 2.3.1 Affinity Chromatography 26 2.3.2 High Performance Liquid Chromatography 27 2.3.3 Proteomics: Multidimensional Protein Identification Technology 28 2.4 Autoradiography 30 2.5 Immunohistochemical Methods 31 2.6 In situ Hybridization 33 2.7 Staining and Neuroanatomical Tract Tracing 34 2.8 Electrophysiology 36 2.8.1 In vivo Recording 36 VI Contents 2.8.2 In vitro Recording 37 2.9 Behavioral Testing 41 2.9.1 Classic Conditioning 41 2.9.2 Operant Conditioning 42 2.9.3 Further Behavioral Tests 42 3 Neurotransmitters 46 3.1 Acetylcholine 46 3.1.1 General Aspects and History 46 3.1.2 Localization Within the Central Nervous System 47 3.1.3 Biosynthesis and Degradation 48 3.1.4 Receptors and Signal Transduction 49 3.1.5 Biological Effects 55 3.1.6 Neurological Disorders and Neurogenerative Diseases 57 3.2 Dopamine 59 3.2.1 General Aspects and History 59 3.2.2 Differentiation and Localization of the Dopaminergic System 60 3.2.3 Biosynthesis and Degradation 62 3.2.4 Release, Re-uptake and Degradation 64 3.2.5 Receptors and Signal Transduction 65 3.2.6 Biological Effects 69 3.2.7 Neurological Disorders and Neurodegenerative Diseases 70 3.3 c-Amino Butyric Acid 75 3.3.1 General Aspects and History 75 3.3.2 Localization Within the Central Nervous System 75 3.3.3 Biosynthesis and Degradation 76 3.3.4 GABA Transporters 77 3.3.5 Receptors and Signal Transduction 78 3.3.6 Biological Effects 84 3.3.7 Neurological Disorders and Neurogenerative Diseases 85 3.4 Glutamate and Aspartate 90 3.4.1 General Aspects and History 90 3.4.2 Localization Within the Central Nervous System 91 3.4.3 Biosynthesis and Degradation 92 3.4.4 Transporters 92 3.4.5 Receptors and Signal Transduction 93 3.4.6 Biological Effects 103 3.4.7 Neurological Disorders and Neurodegenerative Diseases 106 3.5 Glycine 108 3.5.1 General Aspects and History 108 3.5.2 Localization Within the Central Nervous System 109 3.5.3 Biosynthesis and Degradation 109 3.5.4 Receptors and Signal Transduction 110 3.5.5 Biological Effects 113 3.5.6 Neurological Disorders and Neurodegenerative Diseases 113 Contents VII 3.6 Histamine 114 3.6.1 General Aspects and History 114 3.6.2 Localization Within the Central Nervous System 115 3.6.3 Biosynthesis and Degradation 116 3.6.4 Receptors and Signal Transduction 117 3.6.5 Biological Effects 119 3.6.6 Neurological Disorders and Neurodegenerative Diseases 121 3.7 Norepinephrine 123 3.7.1 General Aspects and History 123 3.7.2 Localization Within the Central Nervous System 123 3.7.3 Biosynthesis and Degradation 125 3.7.4 Receptors and Signal Transduction 127 3.7.5 Biological Effects 129 3.7.6 Neurological Disorders and Neurodegenerative Diseases 130 3.8 Serotonin (5-Hydroxytryptamine) 132 3.8.1 General Aspects and History 132 3.8.2 Localization Within the Central Nervous System 133 3.8.3 Biosynthesis and Degradation 133 3.8.4 Receptors and Signal Transduction 135 3.8.5 Biological Effects 139 3.8.6 Neurological Disorders and Neurodegenerative Diseases 139 4 Neuromodulators 144 4.1 Adrenocorticotropic Hormone 144 4.1.1 General Aspects and History 144 4.1.2 Localization Within the Central Nervous System 145 4.1.3 Biosynthesis and Degradation 145 4.1.4 Receptors and Signal Transduction 145 4.1.5 Biological Effects 146 4.1.6 Neurological Disorders and Neurodegenerative Diseases 147 4.2 Anandamide (Endocannabinoids) 149 4.2.1 General Aspects and History 149 4.2.2 Localization Within the Central Nervous System 150 4.2.3 Biosynthesis and Degradation 150 4.2.4 Receptors and Signal Transduction 152 4.2.5 Biological Effects 155 4.2.6 Neurological Disorders and Neurodegenerative Diseases 156 4.3 Angiotensin 158 4.3.1 General Aspects and History 158 4.3.2 Localization Within the Central Nervous System 159 4.3.3 Biosynthesis and Degradation 159 4.3.4 Receptors and Signal Transduction 162 4.3.5 Biological Effects 165 4.3.6 Neurological Disorders and Neurodegenerative Diseases 166 4.4 Atrial Natriuretic Factor 169 VIII Contents 4.4.1 General Aspects and History 169 4.4.2 Localization Within the Central Nervous System 169 4.4.3 Biosynthesis and Degradation 170 4.4.4 Receptors and Signal Transduction 171 4.4.5 Biological Effects 172 4.4.6 Neurological Disorders and Neurodegenerative Diseases 173 4.5 Bombesin and Related Neuropeptides 175 4.5.1 General Aspects and History 175 4.5.2 Localization Within the Central Nervous System 175 4.5.3 Biosynthesis and Degradation 176 4.5.4 Receptors and Signal Transduction 176 4.5.5 Biological Effects 177 4.6 Calcitonin and Calcitonin Gene-related Protein 178 4.6.1 General Aspects and History 178 4.6.2 Localization Within the Central Nervous System 179 4.6.3 Biosynthesis and Degradation 180 4.6.4 Receptors and Signal Transduction 180 4.6.5 Biological Effects 182 4.6.6 Neurological Disorders and Neurodegenerative Diseases 183 4.7 Cholecystokinin 184 4.7.1 General Aspects and History 184 4.7.2 Localization Within the Central Nervous System 185 4.7.3 Biosynthesis and Degradation 186 4.7.4 Receptors and Signal Transduction 187 4.7.5 Biological Effects 188 4.7.6 Neurological Disorders and Neurodegenerative Diseases 190 4.8 Corticotropin-releasing Factor 192 4.8.1 General Aspects and History 192 4.8.2 Localization Within the Central Nervous System 192 4.8.3 Biosynthesis and Degradation 194 4.8.4 Receptors and Signal Transduction 195 4.8.5 Biological Effects 196 4.8.6 Neurological Disorders and Neurodegenerative Diseases 196 4.9 Dynorphin 199 4.9.1 General Aspects and History 199 4.9.2 Localization Within the Central Nervous System 200 4.9.3 Biosynthesis and Degradation 201 4.9.4 Receptors and Signal Transduction 202 4.9.5 Biological Effects 203 4.9.6 Neurological Disorders and Neurodegenerative Diseases 203 4.10 Eicosanoids and Arachidonic Acid 205 4.10.1 General and History Aspects 205 4.10.2 Biosynthesis and Degradation 206 4.10.3 Receptors and Signal Transduction 207 4.10.4 Biological Effects 208 Contents IX 4.10.5 Neurological Disorders and Neurodegenerative Diseases 208 4.11 Endorphin 211 4.11.1 General Aspects and History 211 4.11.2 Localization Within the Central Nervous System 211 4.11.3 Biosynthesis and Degradation 211 4.11.4 Biological Effects 214 4.11.5 Neurological Disorders and Neurodegenerative Diseases 215 4.12 Enkephalin 216 4.12.1 General Aspects and History 216 4.12.2 Localization Within the Central Nervous System 217 4.12.3 Biosynthesis and Degradation 218 4.12.4
Recommended publications
  • Functional Impact of Interacting Protein on Kainate Receptors: Necab1 and Neto Proteins
    Instituto de Neurociencias de Alicante Universidad Miguel Hernandez Thesis manuscript for: PhD in Neuroscience Functional impact of interacting protein on kainate receptors: NeCaB1 and NeTo proteins. Jon Palacios Filardo Supervised by: Prof. Juan Lerma Alicante, 2014 Agradecimientos/Acknowledgments Agradecimientos/Acknowledgments Ahora que me encuentro escribiendo los agradecimientos, me doy cuenta que esta es posiblemente la única sección de la tesis que no será corregida. De manera que los escribiré tal como soy, tal vez un poco caótico. En primer lugar debo agradecer al profesor Juan Lerma, por la oportunidad que me brindó al permitirme realizar la tesis en su laboratorio. Más que un jefe ha sido un mentor en todos estos años, 6 exactamente, en los que a menudo al verme decía: “Jonny cogió su fusil”, y al final me entero que es el título de una película de cine… Pero aparte de un montón de anécdotas graciosas, lo que guardaré en la memoria es la figura de un mentor, que de ciencia todo lo sabía y le encantaba compartirlo. Sin duda uno no puede escribir un libro así (la tesis) sin un montón de gente alrededor que te enseña y ayuda. Como ya he dicho han sido 6 años conviviendo con unos maravillosos compañeros, desde julio de 2008 hasta presumiblemente 31 de junio de 2014. De cada uno de ellos he aprendido mucho; técnicamente toda la electrofisiología se la debo a Ana, con una paciencia infinita o casi infinita. La biología molecular me la enseñó Isa. La proteómica la aprendí del trío Esther-Ricado-Izabella. Joana y Ricardo me solventaron mis primeras dudas en el mundo de los kainatos.
    [Show full text]
  • Molekuláris Bionika És Infobionika Szakok Tananyagának Komplex Fejlesztése Konzorciumi Keretben
    PETER PAZMANY SEMMELWEIS CATHOLIC UNIVERSITY UNIVERSITY Development of Complex Curricula for Molecular Bionics and Infobionics Programs within a consortial* framework** Consortium leader PETER PAZMANY CATHOLIC UNIVERSITY Consortium members SEMMELWEIS UNIVERSITY, DIALOG CAMPUS PUBLISHER The Project has been realised with the support of the European Union and has been co-financed by the European Social Fund *** **Molekuláris bionika és Infobionika Szakok tananyagának komplex fejlesztése konzorciumi keretben ***A projekt az Európai Unió támogatásával, az Európai Szociális Alap társfinanszírozásával valósul meg. 11/25/2011. TÁMOP – 4.1.2-08/2/A/KMR-2009-0006 1 Peter Pazmany Catholic University Faculty of Information Technology www.itk.ppke.hu BASICS OF NEUROBIOLOGY Neurobiológia alapjai IONOTROPIC RECEPTORS (Ionotrop receptorok) ZSOLT LIPOSITS 11/25/2011. TÁMOP – 4.1.2-08/2/A/KMR-2009-0006 2 Basics of Neurobiology: Ionotropic receptors www.itk.ppke.hu TRANSMITTER RECEPTORS WITH THE EXCEPTION OF STEROID SIGNALS AND UNCONVENTIONAL GAS TRANSMIT- TERS (NO, CO), REGULAR NEUROMESSENGERS CAN NOT DIFFUSE THROUGH THE CELL MEMBRANE THEIR EFFECTS ARE MEDIATED BY RECEPTORS THAT ARE EMBEDDED INTO THE POST- SYNAPTIC MEMBRANE RECEPTORS ARE COMPLEX PROTEINS THAT SHOW HIGH-AFFINITY BINDING FOR TRANSMITTER LIGANDS LIGAND BINDING ALTERS THE CONFORMATION OF THE RECEPTOR THAT EVOKES POSTSYNAPTIC RESPONSES THE RESPONSE DEPENDS ON THE AMOUNT OF THE TRANSMITTER, THE NUMBER AND STATE OF THE RECEPTORS TRANSMITTER RECEPTORS BELONG TO TWO CATEGORIES: IONOTROPIC RECEPTORS METABOTROPIC RECEPTORS 11/25/2011. TÁMOP – 4.1.2-08/2/A/KMR-2009-0006 3 Basics of Neurobiology: Ionotropic receptors www.itk.ppke.hu TRANSMITTER RECEPTORS IONOTROPIC RECEPTORS FORM PORES, SPECIFIC ION CHANNELS IN THE MEMBRANE THAT ALLOW THE PASSAGE OF IONS UPON ACTIVATION.
    [Show full text]
  • I. Glur6 Kainate Receptors
    University of Calgary PRISM: University of Calgary's Digital Repository Cumming School of Medicine Cumming School of Medicine Research & Publications 2009-02 Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors Ouardouz, Mohamed; Basak, Ajoy; Chen, Andrew; Rehak, Renata; Yin, Xinghua; Coderre, Elaine M.; Zamponi, Gerald W.; Hameed, Shahid; Trapp, Bruce D. T.; Stys, Peter K.... Wiley-Liss, Inc. Ouardouz, M., Coderre, E., Basak, A., Chen, A., Zamponi, G. W., Hameed, S., … Stys, P. K. (2009). Glutamate receptors on myelinated spinal cord axons: I. glur6 kainate receptors. Annals of Neurology, 65(2), 151–159. https://doi.org/10.1002/ana.21533 http://hdl.handle.net/1880/106670 unknown https://creativecommons.org/licenses/by/4.0 Downloaded from PRISM: https://prism.ucalgary.ca Glutamate Receptors on Myelinated Spinal Cord Axons: I. GluR6 Kainate Receptors Mohamed Ouardouz, PhD,1 Elaine Coderre,1 Ajoy Basak, PhD,2 Andrew Chen, BSc,2 Gerald W. Zamponi, PhD,3 Shameed Hameed, PhD,3 Renata Rehak, MSc,3 Xinghua Yin, MD,4 Bruce D. Trapp, PhD,4 and Peter K. Stys, MD5 Objective: The deleterious effects of glutamate excitotoxicity are well described for central nervous system gray matter. Although overactivation of glutamate receptors also contributes to axonal injury, the mechanisms are poorly understood. Our goal was to ϩ elucidate the mechanisms of kainate receptor–dependent axonal Ca2 deregulation. ϩ Methods: Dorsal column axons were loaded with a Ca2 indicator and imaged in vitro using confocal laser-scanning micros- copy. ϩ Results: Activation of glutamate receptor 6 (GluR6) kainate receptors promoted a substantial increase in axonal [Ca2 ].
    [Show full text]
  • Inhibitory Effects of Glutamate-Stimulated Astrocytes on Action Potentials Evoked by Bradykinin in Cultured Dorsal Root Ganglion Neurons
    Tokai J Exp Clin Med., Vol. 39, No. 1, pp. 14-24, 2014 Inhibitory Effects of Glutamate-stimulated Astrocytes on Action Potentials Evoked by Bradykinin in Cultured Dorsal Root Ganglion Neurons Kazuo SUZUKI, Minehisa ONO and Kenji TONAKA Department of Biomedical Engineering, Tokai University (Received September 26, 2013; Accepted January 20, 2014) Patch-clamp and Ca2+-imaging techniques have revealed that astrocytes have dynamic properties including ion channel activity and release of neurotransmitters, such as adenosine triphosphate (ATP) and glutamate. Here, we used the patch-clamp technique to determine whether ATP and glutamate is able to modulate the bradykinin (BK) response in neurons cultured with astrocytes in the mouse dorsal root ganglia (DRG) in order to clarify the role of astrocytes in nociceptive signal transmission. Astrocytes were identified using a fluorescent anti-GFAP antibody. The membrane potential of astrocytes was about -39 mV. The application of glutamic acid (GA) to the bath evoked the opening of two types of Cl- channel in the astrocyte cell membrane with a unit conductance of about 380 pS and 35 pS in the cell-attached mode, respectively. ATP application evoked the opening of two types of astrocyte K+ channel with a unit conductance of about 60 pS and 29 pS, respectively. Application of BK to the neuron evoked an action potential (spike). Concomitant BK application with ATP increased the frequency of BK-evoked neuron spikes when neurons coexisted with astrocytes. Stimulation of BK with GA inhibited the BK-evoked spike under similar conditions. The application of furosemide, a potent cotransporter (Na+-K+-2Cl-) inhibitor, prior to stimulation of BK with GA blocked inhibition of the spike.
    [Show full text]
  • Specificity in Glycosylation of Multiple Flagellins by the Modular and Cell
    RESEARCH ARTICLE Specificity in glycosylation of multiple flagellins by the modular and cell cycle regulated glycosyltransferase FlmG Silvia Ardissone†, Nicolas Kint, Patrick H Viollier* Department of Microbiology & Molecular Medicine, Faculty of Medicine / CMU, University of Geneva, Gene`ve, Switzerland Abstract How specificity is programmed into post-translational modification of proteins by glycosylation is poorly understood, especially for O-linked glycosylation systems. Here we reconstitute and dissect the substrate specificity underpinning the cytoplasmic O-glycosylation pathway that modifies all six flagellins, five structural and one regulatory paralog, in Caulobacter crescentus, a monopolarly flagellated alpha-proteobacterium. We characterize the biosynthetic pathway for the sialic acid-like sugar pseudaminic acid and show its requirement for flagellation, flagellin modification and efficient export. The cognate NeuB enzyme that condenses phosphoenolpyruvate with a hexose into pseudaminic acid is functionally interchangeable with other pseudaminic acid synthases. The previously unknown and cell cycle-regulated FlmG protein, a defining member of a new class of cytoplasmic O-glycosyltransferases, is required and sufficient for flagellin modification. The substrate specificity of FlmG is conferred by its N-terminal flagellin- binding domain. FlmG accumulates before the FlaF secretion chaperone, potentially timing flagellin modification, export, and assembly during the cell division cycle. *For correspondence: [email protected] Present address: †Center for Research on Intracellular Introduction Bacteria, Institute of Post-translational protein modification is essential for various facets in cellular biology, ranging from Microbiology, University Hospital Center and University of gene regulation to the organization of cellular structures. In all cases, biological function underlies Lausanne, Bugnon, Switzerland the capacity to specifically identify and modify the correct target protein.
    [Show full text]
  • Manipulation of Metabotropic and AMPA Glutamate Receptors in the Brain
    Manipulation of Metabotropic and AMPA Glutamate Receptors in the Brain ©Amy G. M. Lam, B.Sc. Hons (University of London) A thesis submitted for the Degree of Doctor of Philosophy to the Faculty of Medicine, University of Glasgow Wellcome Surgical Institute & Hugh Fraser Neuroscience Laboratories, University of Glasgow, Garscube Estate, Bearsden Road, Glasgow G61 1QH March 1999 ProQuest Number: 11007789 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 11007789 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 O SGOW b DIVERSITY LIBRARY Co| Declaration I declare that this thesis comprises my own original work and has not been accepted in any previous application for a degree. The work, of which it is a record, has been carried out by myself, except as acknowledged and indicated in the thesis. All sources of information have been specifically referenced. Amy Lam Acknowledgements This thesis would not have been possible without the assistance and support of many people. First and foremost, my greatest thanks go to Professor James McCulloch for his never-failing support over the past few years.
    [Show full text]
  • 7Th International Congress on Amino Acids and Proteins Vienna, Austria
    Amino Acids (2001) 21: 1–90 7th International Congress on Amino Acids and Proteins Vienna, Austria August 6–10, 2001 Abstracts Co-Presidents: Steve Schaffer, Mobilel, AL, U.S.A. Michael Fountoulakis, Basel, Switzerland Gert Lubec, Vienna, Austria Contents Analysis................................................................................ 3 Biology ................................................................................ 10 Proteomics . 14 Medicine . 22 Metabolism/Nutrition . 25 Neurobiology . 35 Neuroscience . 45 Plant Amino Acids . 56 Physiology/Exercise and Sport . 59 Polyamines . 63 Synthesis . 68 Taurine ................................................................................ 74 Amino Acids Transport . 79 Addendum . 86 3 Analysis Fully automated HPLC based analysis of cysteine and related used for calculation of the degree of substitution in case of compounds in plasma using on line microdialysis as sample peptide-conjugates. The results of amino acid analysis were preparation verified by the data of ES mass spectrometry method. [This study was supported by grants from Hungarian E. Bald Research Fund (OTKA) T 030838, T025834, T032425, F034886 Department of Environmental Chemistry, University of ´Lodz´, and from the Ministry of Education (FKFP/0153/2001).] Poland Low molecular weight thiols play important roles in metabolism and homeostasis. While plasma thiols, including Free and bound cysteine in homocystinuria: assessment of metabolically related cysteine, glutathione, and homocysteine, cysteine and glutathione status are being investigated as potential indicators of health status A. Briddon1, I. P. Hargreaves1, and P. J. Lee2 and disease risk, trace levels, poor stability, and the lack of 1 structural properties necessary for the production of signals Department of Clinical Biochemistry, and compatible with common detection methods have hampered 2 Metabolic Unit, The National Hospital for Neurology and their accurate assessment. The facile oxidation of sulfhydryl Neurosurgery, London, U.K.
    [Show full text]
  • The Genus Crataegus: Chemical and Pharmacological Perspectives Dinesh Kumar Et Al
    Revista Brasileira de Farmacognosia Brazilian Journal of Pharmacognosy The genus Crataegus: chemical and 22(5): 1187-1200, Sep./Oct. 2012 pharmacological perspectives Dinesh Kumar,*,1 Vikrant Arya,2 Zulfi qar Ali Bhat,1 Nisar Ahmad Khan,1 Deo Nandan Prasad3 1Department of Pharmaceutical Sciences, University of Kashmir, India, 2ASBASJSM College of Pharmacy, Bela Ropar, Punjab, India, Review 3Shivalik College of Pharmacy, Naya-Nangal, Punjab, India. Abstract: Traditional drugs have become a subject of world importance, with both Received 9 Sep 2011 medicinal and economical implications. A regular and widespread use of herbs Accepted 9 Apr 2012 throughout the world has increased serious concerns over their quality, safety and Available online 16 Aug 2012 efficacy. Thus, a proper scientific evidence or assessment has become the criteria for acceptance of traditional health claims. Plants of the genus Crataegus, Rosaceae, are widely distributed and have long been used in folk medicine for the treatment of Keywords: various ailments such as heart (cardiovascular disorders), central nervous system, Crataegus immune system, eyes, reproductive system, liver, kidney etc. It also exhibits wide flavonoids hawthorn range of cytotoxic, gastroprotective, anti-inflammatory, anti-HIV and antimicrobial maloideae/Rosaceae activities. Phytochemicals like oligomeric procyanidins, flavonoids, triterpenes, thorny bush polysaccharides, catecholamines have been identified in the genus and many of these have been evaluated for biological activities. This review presents comprehensive information on the chemistry and pharmacology of the genus together with the traditional uses of many of its plants. In addition, this review discusses the clinical ISSN 0102-695X trials and regulatory status of various Crataegus plants along with the scope for http://dx.doi.org/10.1590/S0102- future research in this aspect.
    [Show full text]
  • Kainate Receptors and Synaptic Transmission James E
    Progress in Neurobiology 70 (2003) 387–407 Kainate receptors and synaptic transmission James E. Huettner∗ Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA Received 20 February 2003; accepted 25 July 2003 Abstract Excitatory glutamatergic transmission involves a variety of different receptor types, each with distinct properties and functions. Physiolog- ical studies have identified both post- and presynaptic roles for kainate receptors, which are a subtype of the ionotropic glutamate receptors. Kainate receptors contribute to excitatory postsynaptic currents in many regions of the central nervous system including hippocampus, cortex, spinal cord and retina. In some cases, postsynaptic kainate receptors are co-distributed with ␣-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA) and N-methyl-d-aspartate (NMDA) receptors, but there are also synapses where transmission is mediated exclusively by postsynaptic kainate receptors: for example, in the retina at connections made by cones onto off bipolar cells. Modulation of transmitter release by presynaptic kainate receptors can occur at both excitatory and inhibitory synapses. The depolarization of nerve terminals by current flow through ionotropic kainate receptors appears sufficient to account for most examples of presynaptic regulation; however, a number of studies have provided evidence for metabotropic effects on transmitter release that can be initiated by activation of kainate receptors. Recent analysis of knockout mice lacking one or more of the subunits that contribute to kainate receptors, as well as studies with subunit-selective agonists and antagonists, have revealed the important roles that kainate receptors play in short- and long-term synaptic plasticity.
    [Show full text]
  • In Vitro Characterization of NS3763, a Non-Competitive Antagonist of GLUK5 Receptors
    JPET Fast Forward. Published on February 25, 2004 as DOI: 10.1124/jpet.103.062794 JPET FastThis Forward.article has not Published been copyedited on and February formatted. The25, final 2004 version as DOI:10.1124/jpet.103.062794may differ from this version. JPET #62794 1 In vitro characterization of NS3763, a non-competitive antagonist of GLUK5 receptors Jeppe K. Christensen, Thomas Varming, Philip K. Ahring, Tino D. Jørgensen and Elsebet Ø. Nielsen NeuroSearch A/S, 93 Pederstrupvej, DK-2750 Ballerup, Denmark Downloaded from jpet.aspetjournals.org at ASPET Journals on October 1, 2021 Copyright 2004 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on February 25, 2004 as DOI: 10.1124/jpet.103.062794 This article has not been copyedited and formatted. The final version may differ from this version. JPET #62794 2 Running title: non-competitive GLUK5 antagonist Corresponding author: Dr. Elsebet Ø. Nielsen Department of Receptor Biochemistry NeuroSearch A/S 93 Pederstrupvej DK-2750 Ballerup Downloaded from Denmark Telephone: (+45) 4460 8000 Direct telephone: (+45) 4460 8237 jpet.aspetjournals.org Fax: (+45) 4460 8080 E-mail: [email protected] at ASPET Journals on October 1, 2021 Tables: 1 Figures: 7 References: 40 Words in Abstract: 159 Words in Introduction: 750 Words in Discussion: 910 Section: Neuropharmacology Non-standard abbreviations: AMPA: α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid ATPA: α-amino-3-hydroxy-5- tertbutylisoxazole-4-propionic acid JPET Fast Forward. Published on February 25, 2004 as DOI: 10.1124/jpet.103.062794 This article has not been copyedited and formatted.
    [Show full text]
  • Nutrition & Supplements
    But wait, there's MORE! We can't publish all our items in one catalog - it takes SIX catalogs! Find details about all the 20212020 catalogs we offer throughout —— the year on page 2. 20222021 AzureStandard.com AzureStandard.com | AZURE STANDARD Nutrition & Supplements 971-200-8350 | 971-200-8350 971-200-8350 CATALOG Delivering supplements and so much more! We seek to make your life easier, healthier, and more fulfilling. Your complete set of When you shop with Azure, you can fill your pantry, your 2021 AZURE CATALOGS Nutrition & Supplements kitchen cabinets, your refrigerator, your freezer, your bathroom includes: THE ITEMS IN THIS CATALOG meet a high threshold for quality. Azure requires transparency from all the companies medicine cabinet, your laundry room, your bedside table, and we work with, and we only choose suppliers that produce foods and products made with only natural ingredients. That means you get even your garden shed with natural and organic products. Nutrition & Supplements nutrient-rich foods and products that are minimally processed with no artificial additives, no preservatives, non-GMO, no MSG, no artificial Publishes in February CT032 colors or flavors. That doesn’t mean every item is organic. Some are made with organic ingredients but are not Certified Organic. Some go Explore all of our products on our website at AzureStandard. Health & Beauty far beyond organic. They all are earth-friendly, non-GMO and meticulously chosen for their healthful qualities. com, or request a specific catalog by Publishes inh April CT033 item number (at right). To receive all of our catalogs and sales Household & Family Azure’s Unacceptable Ingredient List: flyers delivered to your door as they become available, add item Publishes in June CT034 Artificial Colors Certified Colors Shellfish Products CT014 to your order for $19.95.
    [Show full text]
  • Tfiìô˜ 69 • T‡¯Ô˜ 2 a Ú›ÏÈÔ˜ – IÔ‡ÓÈÔ˜ 2003
    EÏÏËÓÈÎË I·ÙÚÈÎË TfiÌÔ˜ 69 • T‡¯Ô˜ 2 AÚ›ÏÈÔ˜ – IÔ‡ÓÈÔ˜ 2003 ¶ÂÚȯfiÌÂÓ· ∂ÓËÌÂÚˆÙÈο 93 H ÏÂÈÙÔ˘ÚÁ›· ÙÔ˘ ÊÏÔÈÔ‡ ÙˆÓ ÂÈÓÂÊÚȉ›ˆÓ ÛÙÔ Û‡Ó‰ÚÔÌÔ ¿ÚıÚ· ÙˆÓ ÔÏ˘Î˘ÛÙÈÎÒÓ ˆÔıËÎÒÓ A.H. KÔ‡ÚÙ˘, ¢.K. ¶·Ó›‰Ë˜ 101 YÂÚ·Û‚ÂÛÙÈ·ÈÌ›·: ¢È·ÁÓˆÛÙÈ΋ ÚÔÛ¤ÁÁÈÛË º. °ÎÈÚÙÔ‚›Ù˘, A. X·Ù˙ËÙfiÏÈÔ˜ 113 Yԉԯ›˜ ÙÔ˘ ÁÏÔ˘Ù·ÌÈÎÔ‡ ÔͤԘ ÛÙÔ ÎÂÓÙÚÈÎfi Ó¢ÚÈÎfi Û‡ÛÙËÌ· N. °ÎÔ˘ÁÎÔ˘ÏÈ¿˜, M. AÏÌ¿ÓË 132 O ¯˘Ìfi˜ ÙÔ˘ Vaccinium oxycoccos L. Î·È Ô ÚfiÏÔ˜ ÙÔ˘ ÛÙȘ Ô˘ÚÔÏÔÈÌÒÍÂȘ Î·È ¿ÏϘ ·ı‹ÛÂȘ ÙÔ˘ Ô˘ÚÔÔÈÔÁÂÓÓËÙÈÎÔ‡ Û˘ÛÙ‹Ì·ÙÔ˜ ∞. ∞ÔÛÙÔÏ›‰Ë˜, π. ÃÚ˘ÛÔÁÔÓ›‰Ë˜ ∂Ú¢ÓËÙÈΤ˜ 138 ∂ÈÔÏ·ÛÌfi˜ Ù˘ ¯ÚfiÓÈ·˜ ·ÔÊÚ·ÎÙÈ΋˜ Ó¢ÌÔÓÔ¿ıÂÈ·˜ ÂÚÁ·Û›Â˜ Î·È Ù˘ ÚÈÓ›Ùȉ·˜ ÛÙË µ. ∂ÏÏ¿‰· §. ™È¯ÏÂÙ›‰Ë˜, π. ∆ÛÈfiÙÛÈÔ˜, ¢. ÃψÚfi˜, ∞. °·‚ÚÈËÏ›‰Ë˜, ∂. ¢·ÛηÏÔÔ‡ÏÔ˘, £. ∫ˆÓÛÙ·ÓÙÈÓ›‰Ë˜ 148 ªÂÙ·‚ÔϤ˜ ÙˆÓ ÂȤ‰ˆÓ Ù˘ ‚-ÂÓ‰ÔÚÊ›Ó˘ Û ۯ¤ÛË Ì ÙËÓ Ô˘‰¤ÙÂÚË ÂÓ‰ÔÂÙȉ¿ÛË Î·È ÙÔ ÌÂÙ·ÙÚÂÙÈÎfi ¤Ó˙˘ÌÔ Ù˘ ·ÁÁÂÈÔÙ·Û›Ó˘ ÌÂÙ¿ ¿ÛÎËÛË ·ÓÙÔ¯‹˜ ‰È¿ÚÎÂÈ·˜ ÙÂÛÛ¿ÚˆÓ ÌËÓÒÓ ∏. ∫·ÏÏ›ÛÙÚ·ÙÔ˜, µ. ∫·ÏʷοÎÔ˘, ¶. µÂ˙˘Ú¿ÎË, ƒ. §È¿ÛÎÔ, ∞. ∂˘·ÁÁ¤ÏÔ˘ 154 ¢ÈÂÚ‡ÓËÛË ÙˆÓ ÔͤˆÓ ÛÙÂÊ·ÓÈ·›ˆÓ ÈÛ¯·ÈÌÈÎÒÓ ÂÂÈÛÔ‰›ˆÓ Û ‰È·‚ËÙÈÎÔ‡˜ ·ÛıÂÓ›˜ ∞. µ‹Ù·˜ ∂ӉȷʤÚÔ˘Û˜ 160 ∏·Ù›Ùȉ· ·fi ΢ÙÙ·ÚÔÌÂÁ·ÏÔ˚fi Û ÌË ·ÓÔÛÔηٷÛÙ·Ï̤ÓÔ ÂÓ‹ÏÈη ÂÚÈÙÒÛÂȘ ¢. °ÎÈÛ¿Î˘, π. ª·Ï¿ÓÔ˜, ∫. ¶·Û¯·Ï›‰Ë˜, ∞. ∫·Ú·ÁÈ¿ÓÓ˘, µ.
    [Show full text]